Ryan Porter

Ryan Porter serves as an Assistant Professor at the University of Arkansas for Medical Sciences (UAMS) College of Medicine with dual appointments in the Department of Internal Medicine (Endocrinology Division) and the Department of Orthopaedics. His research program centers on chondrocyte biology and articular cartilage regenerative medicine, focusing on osteoarthritis (OA) pathogenesis and therapeutic interventions. Supported by the National Institutes of Health (NIH), Department of Defense, and institutional grants, his work addresses critical challenges in joint injury recovery and age-related cartilage degeneration.

Dr. Porter's research interests encompass articular cartilage biology, osteoarthritis mechanisms, mesenchymal stromal cell therapies, drug delivery systems for joint tissues, and regenerative medicine approaches. His laboratory investigates why chondrocytes fail to maintain cartilage during OA onset and develops strategies for targeted therapeutic delivery to prevent tissue loss and stimulate repair. This includes pioneering work on cationic carriers for intra-cartilage drug penetration and transgenic models for noninvasive chondrogenesis assessment.

Analysis of his 15 most recent publications reveals a strong focus on cartilage-targeted drug delivery systems (35% of articles), cellular senescence in OA (25%), and genetic models for cartilage repair (20%). His work consistently bridges basic science with translational applications, emphasizing cationic carriers for deep cartilage penetration, molecular mechanisms of age-related versus post-traumatic OA, and stem cell-based regenerative strategies.

Research funding includes multiple NIH awards as Principal or Co-Investigator: R01AR075121 (Intra-cartilage IL-1RA delivery), R21AR071560 (Extracellular vesicles for bone repair), R21AR069253 (Transgenic rat model development), and P20GM125503 (Center for Musculoskeletal Disease Research). He also serves as Co-Investigator on Department of Defense grant HT9425 investigating subchondral bone osteocytes in post-traumatic OA.

Dr. Porter leads a preclinical research laboratory utilizing rodent models of post-traumatic and age-associated osteoarthritis, specializing in intra-articular drug delivery systems, chondrocyte biology assays, and stem cell-based regenerative approaches. His team collaborates extensively with the UAMS Bone and Joint Initiative and Arkansas Biosciences Institute, maintaining active partnerships with orthopaedic surgeons and endocrinologists to translate findings into clinical applications for joint preservation and repair.